COVID vaccines offer drug makers chance to salvage reputation

VILLAINS OR SAVIOURS? The development of COVID-19 vaccines is a public relations coup for the pharmaceutical industry. The arrival of vaccines has boosted public approval for drug companies. Thanks to the blanket press coverage of the global race to develop vaccines, “big pharma” brands like Pfizer, Moderna and AstraZeneca have become household names. The long-beleaguered … Continue reading COVID vaccines offer drug makers chance to salvage reputation